Evaluation of safety of increased time interval between chemoradiation and resection for rectal cancer

American Journal of Surgery

Volumn 192, Issue 6, 2006, Pages 873-877

  Tran, Cam Ly ^a   Udani, Sejal ^b   Holt, Alicia ^c   Arnell, Tracey ^d   Kumar, Ravin ^c   Stamos, Michael J ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b PACE UNIVERSITY   (United States)

^c HARBOR UCLA MEDICAL CENTER   (United States)

^d Columbia University ^*  (United States)

Author keywords

Chemoradiation; Neoadjuvant; Rectal cancer

Indexed keywords

FLUOROURACIL;

ADJUVANT THERAPY; ADULT; AGED; ARTICLE; BLEEDING; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HOSPITAL READMISSION; HUMAN; LENGTH OF STAY; MALE; MORTALITY; OPERATION DURATION; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; RECTUM CANCER; RETROSPECTIVE STUDY; SAFETY;

ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOADJUVANT THERAPY; NEOPLASM STAGING; RADIOTHERAPY; RECTAL NEOPLASMS; RETROSPECTIVE STUDIES; TIME FACTORS;

EID: 33845243360     PISSN: 00029610     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjsurg.2006.08.061     Document Type: Article

References (16)

1. Jemal A., Murray T., Ward E., et al. Cancer statistics, 2005. CA Cancer J Clin 55 (2005) 10-30
2. NIH consensus conference. Adjuvant therapy for patients with colon and rectal cancer. JAMA 264 (1990) 1444-1450
3. Sauer R., Becker H., Hohenberger W., et al., German Rectal Cancer Study Group. Preoperative versus postoperative chemoradiotherapy for rectal cancer. N Engl J Med 351 (2004) 1731-1740
4. Lam C.W., Chen W.T., Liu M.T., et al. Effect of preoperative concurrent chemoradiotherapy in locally advanced low rectal cancer after radical resection surgery. Int Surg 90 (2005) 53-59
5. Guillem J.G., Chessin D.B., Cohen A.M., et al. Long-term oncologic outcome following preoperative combined modality therapy and total mesorectal excision of locally advanced rectal cancer. Ann Surg 241 (2005) 829-836 discussion 836-8
6. Nudelman I.L., Fuko V., Geller A., et al. Treatment of rectal cancer by chemoradiation followed by surgery: analysis and early clinical outcome in 66 patients. Isr Med Assoc J 7 (2005) 377-380
7. Biondo S., Navarro M., Marti-Rague J., et al. Response to neoadjuvant therapy for rectal cancer: influence on long-term results. Colorectal Dis 7 (2005) 472-479
8. Folkesson J., Birgisson H., Pahlman L., et al. Swedish Rectal Cancer Trial: long lasting benefits from radiotherapy on survival and local recurrence rate. J Clin Oncol 235 (2005) 644-650
9. Theodoropoulos G., Wise W.E., Padmanabhan A., et al. T-level downstaging and complete pathologic response after preoperative chemoradiation for advanced rectal cancer result in decreased recurrence and improved disease-free survival. Dis Colon Rectum 45 (2002) 895-903
10. Minsky B.D. Adjuvant therapy for rectal cancer-the transatlantic view. Colorectal Dis 5 (2003) 416-422
11. Francois Y., Nemoz C.J., Baulieux J., et al. Influence of the interval between preoperative radiation therapy and surgery on downstaging and on the rate of sphincter-sparing surgery for rectal cancer: the Lyon R90-01 randomized trial. J Clin Oncol 17 (1999) 2396-402
12. Stein D.E., Mahmoud N.N., Anne P.R., et al. Longer time interval between completion of neoadjuvant chemoradiation and surgical resection does not improve downstaging of rectal carcinoma. Dis Colon Rectum 46 (2003) 448-453
13. Moore H.G., Gittleman A.E., Minsky B.D., et al. Rate of pathologic complete response with increased interval between preoperative combined modality therapy and rectal cancer resection. Dis Colon Rectum 47 (2004) 279-286
14. Withers H.R., and Haustermans K. Where next with preoperative radiation therapy for rectal cancer?. Int J Radiat Oncol Biol Phys 58 (2004) 597-602
15. Brierley J.D., Cummings B.J., Wong C.S., et al. Adenocarcinoma of the rectum treated by radical external radiation therapy. Int J Radiat Oncol Biol Phys 31 (1995) 255-259
16. Garcia-Aguilar J, Rothenberger D, Jessurum J, et al. Timing of rectal cancer response to chemoradiation.